CVS Corp
(CVS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 9,098,000 | 11,787,000 | 10,076,000 | 8,586,000 | 6,875,000 |
| Marketable Securities | 2,134,000 | 2,386,000 | 2,578,000 | 2,407,000 | 2,805,000 |
| Receivables | 43,857,000 | 40,651,000 | 39,625,000 | 36,469,000 | 36,179,000 |
| Inventories | 18,962,000 | 17,447,000 | 17,385,000 | 18,107,000 | 17,649,000 |
| Other current assets | 3,058,000 | 3,378,000 | 3,527,000 | 3,076,000 | 3,835,000 |
| TOTAL | $77,109,000 | $75,649,000 | $73,191,000 | $68,645,000 | $67,343,000 |
| Non-Current Assets | |||||
| PPE Net | 12,838,000 | 12,825,000 | 12,856,000 | 12,993,000 | 12,728,000 |
| Investments And Advances | 31,553,000 | 29,858,000 | 28,906,000 | 28,934,000 | 28,939,000 |
| Intangibles | 111,462,000 | 117,427,000 | 117,773,000 | 118,595,000 | 119,089,000 |
| Other Non-Current Assets | 22,365,000 | 22,584,000 | 22,859,000 | 24,048,000 | 24,328,000 |
| TOTAL | $178,218,000 | $182,694,000 | $182,394,000 | $184,570,000 | $185,084,000 |
| Total Assets | $255,327,000 | $258,343,000 | $255,585,000 | $253,215,000 | $252,427,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 5,328,000 | 9,200,000 | 5,670,000 | 5,743,000 | 5,710,000 |
| Accounts payable and accrued liabilities | 60,947,000 | 58,867,000 | 57,443,000 | 55,122,000 | 54,867,000 |
| Accrued Expenses | 23,415,000 | 23,101,000 | 22,369,000 | 20,810,000 | 20,174,000 |
| Other current liabilities | 1,096,000 | 1,088,000 | 1,570,000 | 1,183,000 | 1,964,000 |
| TOTAL | $92,695,000 | $94,162,000 | $88,961,000 | $84,609,000 | $84,627,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 60,508,000 | 57,290,000 | 59,040,000 | 60,527,000 | 59,824,000 |
| Other Non-Current Liabilities | 25,482,000 | 25,745,000 | 26,807,000 | 28,564,000 | 29,254,000 |
| TOTAL | $89,522,000 | $86,630,000 | $89,514,000 | $92,876,000 | $92,694,000 |
| Total Liabilities | $182,217,000 | $180,792,000 | $178,475,000 | $177,485,000 | $177,321,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,269,432 | 1,268,326 | 1,265,019 | 1,260,795 | 1,258,408 |
| Common Shares | 50,181,000 | 50,020,000 | 49,837,000 | 49,661,000 | 49,510,000 |
| Retained earnings | 59,107,000 | 63,936,000 | 63,768,000 | 62,837,000 | 62,038,000 |
| Other shareholders' equity | 598,000 | 444,000 | 240,000 | 50,000 | 371,000 |
| TOTAL | $73,110,000 | $77,551,000 | $77,110,000 | $75,730,000 | $75,106,000 |
| Total Liabilities And Equity | $255,327,000 | $258,343,000 | $255,585,000 | $253,215,000 | $252,427,000 |